| | Product | Registr. Holder | Package Size | Composition | CP | % | SB | DC |
---|
IP | | Oxaliplatin Sandoz 200 mg/40 ml | Sandoz Pharmaceuticals AG | | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | 302.15 | | 10 % | |
IP | | Oxaliplatin Accord 50 mg/10 ml | Accord Healthcare AG | | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | 99.80 | -66% | 10 % | |
IP | | Oxaliplatin Sandoz 50 mg/10 ml | Sandoz Pharmaceuticals AG | | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | 99.80 | -66% | 10 % | |
IP | | Oxaliplatin Zentiva 50 mg/10 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | 99.80 | -66% | 10 % | |
IP | | Oxaliplatin-Teva liquid 50 mg/10 ml | Teva Pharma AG | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | 99.80 | -66% | 10 % | |
IP | | Eloxatine 50 mg/10 ml | Sanofi-Aventis (Suisse) SA | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | 107.65 | -64% | 10 % | |
IP | | Oxaliplatin Accord 100 mg/20 ml | Accord Healthcare AG | | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | 182.55 | -39% | 10 % | |
IP | | Oxaliplatin Sandoz 100 mg/20 ml | Sandoz Pharmaceuticals AG | | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | 182.55 | -39% | 10 % | |
IP | | Oxaliplatin Zentiva 100 mg/20 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | 182.55 | -39% | 10 % | |
IP | | Oxaliplatin-Teva liquid 100 mg/20 ml | Teva Pharma AG | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | 182.55 | -39% | 10 % | |
IP | | Eloxatine 100 mg/20 ml | Sanofi-Aventis (Suisse) SA | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | 198.20 | -34% | 10 % | |
IP | | Oxaliplatin Accord 200 mg/40 ml | Accord Healthcare AG | | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | 302.15 | +0% | 10 % | |
IP | | Oxaliplatin Zentiva 200 mg/40 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | 302.15 | +0% | 10 % | |
IP | | Oxaliplatin-Teva liquid 200 mg/40 ml | Teva Pharma AG | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | 302.15 | +0% | 10 % | |
IP | | Eloxatine 200 mg/40 ml | Sanofi-Aventis (Suisse) SA | Durchstechflasche(n) | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | 329.15 | +8% | 10 % | |
IP | | Helveplatin 100 mg/20 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 100mg / 20ml | PR | | k.A. | |
IP | | Helveplatin 200 mg/40 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 200mg / 40ml | PR | | k.A. | |
IP | | Helveplatin 50 mg/10 ml | Helvepharm AG | | Concentrate for infusion: Oxaliplatinum 50mg / 10ml | PR | | k.A. | |
IP | | Oxaliplatin Sandoz 250 mg/50 ml | Sandoz Pharmaceuticals AG | | Concentrate for infusion: Oxaliplatinum 250mg / 50ml | PR | | k.A. | |